Risk factors

Bar Harbor Bankshares relies primarily on net interest income, with 67% of its loan portfolio concentrated in commercial real estate, commercial and industrial, and construction loans across Maine, New Hampshire, and Vermont. The company faces significant risk from interest rate volatility, maintaining regulatory capital and liquidity requirements, and managing cyber security and operational disruptions. Overdraft protection fees represent a key component of noninterest income and face heightened regulatory scrutiny.

Backblaze carries significant accumulated deficits with ongoing net losses of $48.5 million in 2024 and $59.7 million in 2023. Operations depend heavily on third-party data centers, hard drive suppliers, and payment processors like Stripe. Growth requires successfully expanding into larger mid-market organizations against dominant cloud competitors like AWS and Google.

Risk factors are dominated by reliance on HA products, EXOGEN regulatory changes, third-party manufacturing, and stringent compliance requirements.

Credit losses are concentrated in Florida and Georgia real estate lending, especially commercial, construction, vacant-land and mortgage loans.

This initial risk section is dominated by product liability, government contracting exposure, supplier dependencies, and acquisition risks.

Core Molding Technologies faces heavy customer concentration with 69% of 2024 sales tied to five customers. The business relies heavily on the cyclical North American heavy and medium-duty truck industry, representing 56% of sales. Union representation covers 67.4% of the workforce across facilities in Ohio, Mexico, and Canada.

ChoiceOne Financial Services faces heavy credit exposure to commercial and residential real estate loans within Michigan.

The company relies heavily on local discretionary spending for its casino and horse racing operations. Revenue is exposed to regional competition from tribal casinos and Running Aces. Real estate development partnerships and tax increment financing represent key diversification strategies.

Clinical trials for drug candidate CRB-701 rely heavily on external partners like CSPC in China. Operations depend entirely on clinical success with no commercial products or revenues yet. Substantial ongoing losses are funded by existing cash reserves of $149.1 million.

Accumulated deficit reached $54,082,484 as of December 31, 2024, with continued net losses expected. Substantially all revenue depends on U.S. federal, state, and local government contracts. Total indebtedness stands at $10,399,944, with maturities extended to 2026.

Datacentrex is an early-stage company generating minimal revenue with a net loss of $3,999,905 in 2024. The company relies heavily on equity financing and key personnel like CEO Robert Steele. Operations face significant risks regarding the Thumzup App, cybersecurity, third-party software, and a newly adopted volatile bitcoin strategy.

Elutia faces going concern doubts after posting a 2024 net loss of $53.9 million alongside $23.9 million in debt.